Budgeting for Opioid Addiction Treatment Act (HR 2038 / S 523, 115th Congress)
What it does
Amends the Internal Revenue Code of 1986 to establish a stewardship fee on the production and importation of opioid pain relievers.
HR 2038 / S 523, the Budgeting for Opioid Treatment Act, would establish a $0.01 / milligram "stewardship fee" for active opioid products sold by the manufacturer, producer, or importer of those products. This new revenue would be directed to the States to fund substance abuse initiatives, such as establishing new treatment facilities, hiring new mental health providers, or expanding access to long-term, residential treatment programs.